Medivir AB (publ) Stock OTC Markets
Equities
MVRBF
SE0020181014
Biotechnology & Medical Research
Sales 2024 * | 26.75M 2.42M | Sales 2025 * | 52.18M 4.73M | Capitalization | 353M 31.99M |
---|---|---|---|---|---|
Net income 2024 * | -96M -8.7M | Net income 2025 * | -93M -8.43M | EV / Sales 2024 * | 9.65 x |
Net cash position 2024 * | 94.7M 8.58M | Net cash position 2025 * | 58M 5.26M | EV / Sales 2025 * | 5.65 x |
P/E ratio 2024 * |
-3.48
x | P/E ratio 2025 * |
-2.49
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on Medivir AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |